|
mrna processing
|
GO:0006397 |
63 |
0.616
|
|
|
rna processing
|
GO:0006396 |
105 |
0.579
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.398
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.182
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.167
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.149
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.136
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.130
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.115
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.105
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.102
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.097
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.086
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.077
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.074
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.071
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.067
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.066
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.062
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
12 |
0.062
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.057
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.056
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.055
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.052
|
|
|
dna repair
|
GO:0006281 |
107 |
0.052
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.050
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.050
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.049
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.045
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.044
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.043
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.043
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
8 |
0.042
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.042
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.041
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.040
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.039
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.039
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.039
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.039
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.038
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.037
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.037
|
|
|
negative regulation of mrna processing
|
GO:0050686 |
12 |
0.036
|
|
|
regionalization
|
GO:0003002 |
337 |
0.036
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.036
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.035
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.035
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.033
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.033
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.033
|
|
|
rna interference
|
GO:0016246 |
2 |
0.032
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.032
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.032
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.032
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.032
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.031
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.031
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.030
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.030
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.029
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.029
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.029
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.029
|
|
|
gonad development
|
GO:0008406 |
141 |
0.028
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.028
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.027
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.027
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.027
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.027
|
|
|
placenta development
|
GO:0001890 |
140 |
0.027
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.025
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.024
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.024
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.024
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.024
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.023
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.023
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.023
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.022
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.021
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.021
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.021
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.021
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.021
|
|
|
negative regulation of mrna metabolic process
|
GO:1903312 |
13 |
0.021
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.021
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.021
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.020
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.020
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.020
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.020
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.020
|
|
|
action potential
|
GO:0001508 |
78 |
0.020
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.020
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.020
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.020
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.020
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.019
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.019
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.019
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.019
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.018
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.018
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.018
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.018
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.018
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.018
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.017
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.017
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.017
|
|
|
skin development
|
GO:0043588 |
220 |
0.017
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.017
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.017
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.017
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.017
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.017
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.016
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.016
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.016
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.016
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.016
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.016
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.016
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.016
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.016
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.016
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.016
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.016
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.016
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.016
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.016
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.015
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.015
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.015
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.015
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.015
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.015
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.015
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.015
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.015
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.015
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.015
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.015
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.015
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.015
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.015
|
|
|
gland development
|
GO:0048732 |
330 |
0.015
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.014
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.014
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.014
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.014
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.014
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.014
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.014
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.014
|
|
|
primary mirna processing
|
GO:0031053 |
1 |
0.014
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.014
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.014
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.014
|
|
|
negative regulation of mrna splicing via spliceosome
|
GO:0048025 |
12 |
0.014
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.014
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.013
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.013
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.013
|
|
|
protein import
|
GO:0017038 |
101 |
0.013
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.013
|
|
|
regulation of interleukin 1 alpha secretion
|
GO:0050705 |
3 |
0.013
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.013
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.013
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.013
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.013
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.013
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.013
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.013
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.013
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.013
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.013
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.013
|
|
|
cell growth
|
GO:0016049 |
130 |
0.013
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.013
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.012
|
|
|
ncrna processing
|
GO:0034470 |
26 |
0.012
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.012
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.012
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.012
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.012
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.012
|
|
|
snrna metabolic process
|
GO:0016073 |
1 |
0.012
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.012
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.012
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.012
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.012
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.012
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.012
|
|
|
response to heat
|
GO:0009408 |
27 |
0.012
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.012
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.012
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.012
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072040 |
4 |
0.012
|
|
|
negative regulation of rna splicing
|
GO:0033119 |
12 |
0.012
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.012
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.011
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.011
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.011
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.011
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.011
|
|
|
cation transport
|
GO:0006812 |
399 |
0.011
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.011
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.011
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.011
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.011
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.011
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.011
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.011
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.011
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.011
|
|
|
regulation of microtubule polymerization or depolymerization
|
GO:0031110 |
20 |
0.011
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.011
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.011
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.011
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.011
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.011
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.011
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.011
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.011
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.011
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.011
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.011
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.010
|
|
|
histone h3 k4 trimethylation
|
GO:0080182 |
5 |
0.010
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.010
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.010
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.010
|
|
|
histone modification
|
GO:0016570 |
159 |
0.010
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.010
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.010
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.010
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.010
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.010
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.010
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.010
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.010
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.010
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.010
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.010
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.010
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.010
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.010
|
|